1[1]Cunha B A. Antibiotic resistance[J]. Med Clin North Amer, 2000, 84(6): 1407-1429.
2[2]Cunha B A. Community-acquired pneumonia, diagnostic and therapeutic approach[J]. Med.Clin. North Amer, 2001, 85(1): 43-77.
3[3]Magee J T, Pritchard E L, Fitzgerald K A, et al. Antibiotic prescribing and antibiotic resistance in community practice: retrospective study, 1996-1998[J]. Brit. Med J. 1999, 319(7219): 1239-1240.
4[4]Cunha B A. Current concepts in the antimicrobial therapy of community acquired pneumonia [J]. Drugs of Today, 1998, 34(2): 107-123.
5[5]Smith J M, Dowson C G, Spratt B G. Localized sex in bacteria[J]. Nature, 1991, 349: 29-31.
6[6]Cooper R J, Hoffman J R, Bartlett J G, et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: background[J]. Ann. Inter. Med, 2001, 134(6): 509-517.
7[7]Giamarellou H, Antoniadou A. Antipseudomonal antibiotics[J]. Med. Clin. North Amer, 2001, 85(1): 19-42.
8[8]Segreti J, Levin S. Bacteriologic and clinical applications of a new extended-spectrum parenteral cephalosporin[J]. Amer.J. Med. 1996, 100: Suppl 6A: S45-S51.
9[9]Jones R N. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients [J]. Am. J. Med. 1996, 100:Suppl 6A: S3-S12.
10[10]Sanders W E Jr, Tenney J H, Kesslar R E, et al. Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species[J]. Clin. Infect. Dis, 1996, 23(3): 454-461.
